Citicoline is one of the more extensively studied nootropic supplements for safety. The compound has been used as a prescription drug in Japan and parts of Europe for decades, generating a large body of post-marketing surveillance data in addition to controlled clinical trials. The Secades (2022) comprehensive review analyzed safety data across trials involving over 11,000 patients and found adverse event rates comparable to placebo at standard supplemental doses (Secades, 2022).
What Are the Common Side Effects of Citicoline?
The most frequently reported adverse effects are gastrointestinal and mild in nature. A drug surveillance study by Lozano Fernandez (1983) tracked 2,817 patients taking oral citicoline and reported an overall adverse event rate of approximately 5%. The majority of reported events were transient and did not require treatment discontinuation (Lozano Fernandez, 1983).
Stomach discomfort and nausea. The most common complaint across clinical trials. GI symptoms tend to be dose-dependent, with higher doses (1,000-2,000 mg/day) producing more reports than the standard 250-500 mg supplement range.
Diarrhea. Reported in a small percentage of trial participants. Usually resolves without dose adjustment. Taking citicoline with food may reduce the likelihood of diarrhea.
Headache. Occasionally reported, though at rates similar to placebo in controlled studies. The Nakazaki et al. (2021) 12-week RCT using 500 mg/day in healthy older adults reported no significant differences in adverse events between citicoline and placebo groups (Nakazaki et al., 2021).
Insomnia and restlessness. Uncommon at standard doses but documented in the literature. Citicoline increases acetylcholine availability, a neurotransmitter associated with arousal and wakefulness. Individuals who experience sleep disruption should consider morning dosing or dose reduction.
Does Citicoline Interact with Medications?
Two drug interaction categories warrant attention:
Levodopa (Parkinson’s disease medication). Citicoline may enhance the effects of levodopa. In early pharmacological research, citicoline was studied as a potential adjunct to levodopa therapy because both compounds influence dopamine pathways. While this interaction could theoretically be beneficial in a clinical setting, supplement users taking levodopa should consult their prescribing physician before adding citicoline to avoid unpredictable potentiation of dopaminergic effects (Secades & Lorenzo, 2006).
Antipsychotic medications. Citicoline may affect dopaminergic neurotransmission, which could theoretically counteract the dopamine-blocking mechanism of antipsychotic drugs. The Jasielski et al. (2020) systematic review noted that individuals with psychotic conditions or those receiving antipsychotic therapy should exercise caution with citicoline supplementation (Jasielski et al., 2020).
No other significant drug interactions have been reported in the clinical literature. Citicoline does not appear to interact with anticoagulants, antihypertensives, or common supplements.
Is Citicoline Safe for Long-Term Use?
The longest controlled studies of citicoline supplementation extended to 12 months. Alvarez-Sabin et al. (2013) administered 1,000 mg/day citicoline to stroke patients for 12 months with no serious adverse events attributable to citicoline (Alvarez-Sabin et al., 2013). Cohen et al. (2003) similarly found no safety concerns during 12 months of 1,000 mg/day treatment in vascular dementia patients (Cohen et al., 2003).
The Secades (2022) review specifically examined long-term safety across multiple trials and concluded that citicoline’s safety profile remains consistent with extended use, without evidence of cumulative toxicity or organ damage (Secades, 2022).
No evidence of tolerance development has been reported. The compound’s mechanism (providing biosynthetic precursors rather than directly activating receptors) makes pharmacological tolerance unlikely.
Does Citicoline Affect Blood Pressure or Heart Rate?
Citicoline does not appear to have clinically meaningful effects on blood pressure or heart rate at standard supplemental doses. Occasional reports of low blood pressure and rapid heartbeat appear in the broader safety literature but are rare and have not been confirmed in controlled studies.
Individuals taking antihypertensive medications do not appear to be at elevated risk from citicoline supplementation, based on the absence of cardiovascular adverse events across the large patient databases reviewed by Secades (2022).
Who Should Avoid Citicoline?
Pregnant and breastfeeding women. Insufficient safety data exists for citicoline use during pregnancy and lactation. No controlled studies have evaluated citicoline in pregnant populations. The standard recommendation is to avoid supplementation in the absence of safety data.
Individuals with psychotic disorders. Case reports and pharmacological reasoning suggest citicoline’s dopaminergic effects could theoretically exacerbate psychotic symptoms. Individuals with schizophrenia, schizoaffective disorder, or a history of psychotic episodes should not use citicoline without medical supervision.
Children. Clinical trials of citicoline have primarily enrolled adults and adolescents (13+ years). Safety and efficacy in younger children have not been established. The McGlade et al. (2019) study enrolled adolescent males aged 13-18 and reported no adverse events, but this represents a limited dataset (McGlade et al., 2019).
Can You Take Too Much Citicoline?
Acute toxicity risk is very low. Citicoline has been administered at doses up to 2,000 mg/day in clinical trials for acute stroke (Clark et al., 2001) without serious safety concerns (Clark et al., 2001). The EFSA guideline of 500 mg/day for supplements provides a conservative upper boundary for daily use.
At doses above 1,000 mg/day, gastrointestinal side effects become more likely. No cases of citicoline overdose resulting in serious medical consequences have been reported in the published literature. Animal toxicology studies show a wide margin of safety, with LD50 values exceeding 4,000 mg/kg in rodents, well above any human supplementation level (Secades & Frontera, 1995).
Summary of Safety Data
| Parameter | Finding |
|---|---|
| Total patients studied | >11,000 (Secades, 2022) |
| Adverse event rate | ~5%, comparable to placebo |
| Most common side effects | Mild GI (stomach discomfort, nausea, diarrhea) |
| Serious adverse events | None attributable to citicoline at standard doses |
| Longest controlled study | 12 months at 1,000 mg/day |
| Key drug interactions | Levodopa, antipsychotics |
| Populations to avoid | Pregnant/breastfeeding, psychotic disorders |
| EFSA maximum (supplements) | 500 mg/day |
Citicoline is not intended to diagnose, treat, cure, or prevent any disease.